• レポートコード:MRC2403B245 • 出版社/出版日:Transparency Market Research / 2023年12月 • レポート形態:英文、PDF、264ページ • 納品方法:受注後3営業日 • 産業分類:医療 |
Single User | ¥869,250 (USD5,795) | ▷ お問い合わせ |
Multi User | ¥1,319,250 (USD8,795) | ▷ お問い合わせ |
Corporate License | ¥1,769,250 (USD11,795) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
消化管病原体検査市場 - レポートの範囲TMRの調査レポート「消化管病原体検査の世界市場」は、2023年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。レポートでは、2023年を基準年、2031年を予測年として、2017年から2031年までの世界の消化管病原体検査t市場の収益を提供します。また、2023年から2031年までの世界の消化管病原体検査市場の複合年間成長率(CAGR %)も掲載しています。 本レポートは広範な調査を経て作成されました。主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。二次調査では、主要企業の製品資料、年次報告書、プレスリリース、関連文書などを参照し、消化管病原体検査市場を理解した。 二次調査には、インターネット情報源、政府機関の統計データ、ウェブサイト、業界団体なども含まれます。アナリストはトップダウンアプローチとボトムアップアプローチを組み合わせて、世界の消化管病原体検査市場の様々な属性を調査しました。 本レポートには、調査範囲に含まれる様々なセグメントの成長動向のスナップショットとともに、詳細なエグゼクティブサマリーが含まれています。さらに、同レポートは、世界の消化管病原体検査市場における競争ダイナミクスの変化に光を投げかけています。これらは、既存の市場プレイヤーだけでなく、世界の消化管病原体検査市場への参入に関心のある企業にとっても貴重なツールとなります。 本レポートでは、世界の消化管病原体検査市場の競争環境について掘り下げています。世界の消化管病原体検査市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイリングされています。会社概要、財務状況、最近の動向、SWOTは、本レポートで紹介されている世界の消化管病原体検査市場のプレイヤーの属性です。 世界の消化管病原体検査市場レポートで回答された主な質問 - 予測期間中の全地域における胃腸病原体検査tの売上高/収益は? - 世界の消化管病原体検査市場におけるビジネスチャンスは? - 市場の主な促進要因、阻害要因、機会、脅威は何か? - 予測期間中に最も速いCAGRで拡大する地域市場はどこか? - 2031年に世界で最も高い収益を上げると予測されるセグメントは? - 予測期間中に最も高いCAGRで拡大すると予測されるセグメントは? - 世界市場で事業を展開する各企業の市場ポジションは? 消化管病原菌検査市場 - 調査目的と調査アプローチ 消化管病原体検査の世界市場に関する包括的なレポートは、概要から始まり、調査範囲と目的が続きます。本レポートでは、本調査の目的、市場で事業を展開する主要ベンダーや流通業者、製品承認のための規制シナリオについて詳細に解説しています。 本レポートは、読みやすさを考慮し、各セクションを章ごとに分割したレイアウトになっています。本レポートは、グラフや表が適切に散りばめられた網羅的なコレクションで構成されています。主要セグメントの実績値と予測値を図式化し、読者に視覚的に訴えます。また、過去と予測期間末の主要セグメントの市場シェアの比較も可能です。 当レポートでは、世界の消化管病原体検査市場を製品、エンドユーザー、地域の観点から分析しています。各基準の主要セグメントを詳細に調査し、2031年末時点の各セグメントにおける市場シェアを掲載しています。このような貴重な洞察は、市場関係者が世界の消化管病原体検査市場への投資のための情報に基づいたビジネス上の意思決定を行うことを可能にします。 |
1. 序論
2. 仮定・調査手法
3. エグゼクティブサマリー:世界の消化管病原体検査市場
4. 市場概要
5. 主要インサイト
6. 世界の消化管病原体検査市場分析:病原体タイプ別
7. 世界の消化管病原体検査市場分析:検査タイプ
8. 世界の消化管病原体検査市場分析:パネルタイプ別
9. 世界の消化管病原体検査市場分析:エンドユーザー別
10. 世界の消化管病原体検査市場分析:地域別
11. 北米の消化管病原体検査市場分析
12. ヨーロッパの消化管病原体検査市場分析
13. アジア太平洋の消化管病原体検査市場分析
14. 中南米の消化管病原体検査市場分析
15. 中東/アフリカの消化管病原体検査市場分析
16. 競争状況
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Gastrointestinal Pathogen Testing Market
4. Market Overview
4.1. Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Global Gastrointestinal Pathogen Testing Market Value Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Gastrointestinal Disorders: Overview
5.2. Technological Advancements
5.3. Key Industry Events (Key Developments, Partnership, Collaborations etc.)
5.4. Overview of the test type conducted across each of the End users
5.5. COVID-19 Pandemic Impact on Industry
6. Global Gastrointestinal Pathogen Testing Market Analysis, by Pathogen Type
6.1. Introduction
6.2. Global Gastrointestinal Pathogen Testing Market Share Analysis, by Pathogen Type
6.3. Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Pathogen Type
6.4. Global Gastrointestinal Pathogen Testing Market Analysis, by Pathogen Type
6.5. Global Gastrointestinal Pathogen Testing Market Forecast, by Pathogen Type
6.5.1. Bacteria
6.5.1.1. Molecular Tests
6.5.1.2. Culture
6.5.1.3. Biochemical Tests
6.5.1.4. Others
6.5.2. Viruses
6.5.2.1. Molecular Tests
6.5.2.2. Culture
6.5.2.3. Others
6.5.3. Parasites
6.5.3.1. Ova and Parasite Microscopy
6.5.3.2. Molecular Tests
6.5.3.3. Others
7. Global Gastrointestinal Pathogen Testing Market Analysis, by Test Type
7.1. Introduction
7.2. Global Gastrointestinal Pathogen Testing Market Share Analysis, by Test Type
7.3. Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Test Type
7.4. Global Gastrointestinal Pathogen Testing Market Analysis, by Test Type
7.5. Global Gastrointestinal Pathogen Testing Market Forecast, by Test Type
7.5.1. Molecular Tests
7.5.2. Culture
7.5.3. Biochemical Tests
7.5.4. Others
8. Global Gastrointestinal Pathogen Testing Market Analysis, by Panel Type
8.1. Introduction
8.2. Global Gastrointestinal Pathogen Testing Market Share Analysis, by Panel Type
8.3. Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Panel Type
8.4. Global Gastrointestinal Pathogen Testing Market Analysis, by Panel Type
8.5. Global Gastrointestinal Pathogen Testing Market Forecast, by Panel Type
8.5.1. Syndromic Full Multiplex Panels
8.5.2. Others
9. Global Gastrointestinal Pathogen Testing Market Analysis, by End-user
9.1. Introduction
9.2. Global Gastrointestinal Pathogen Testing Market Share Analysis, by End-user
9.3. Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by End-user
9.4. Global Gastrointestinal Pathogen Testing Market Analysis, by End-user
9.5. Global Gastrointestinal Pathogen Testing Market Forecast, by End-user
9.5.1. Hospitals
9.5.1.1. Public
9.5.1.2. Private
9.5.1.3. Others
9.5.2. Diagnostic Laboratories
9.5.3. Point-of-Care
9.5.4. Others
10. Global Gastrointestinal Pathogen Testing Market Analysis, by Region
10.1. Introduction
10.2. Global Gastrointestinal Pathogen Testing Market Share Analysis, by Region
10.3. Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Region
10.4. Global Gastrointestinal Pathogen Testing Market Forecast, by Region
10.4.1. North America
10.4.2. Europe
10.4.3. Asia Pacific
10.4.4. Latin America
10.4.5. Middle East & Africa
11. North America Gastrointestinal Pathogen Testing Market Analysis
11.1. Key Insights: North America Gastrointestinal Pathogen Testing Market
11.2. North America Gastrointestinal Pathogen Testing Market Overview
11.3. North America Gastrointestinal Pathogen Testing Market Forecast, by Country
11.3.1. U.S.
11.3.2. Canada
11.4. North America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Pathogen Type
11.5. North America Gastrointestinal Pathogen Testing Market Forecast, by Pathogen Type
11.5.1. Bacteria
11.5.1.1. Molecular Tests
11.5.1.2. Culture
11.5.1.3. Biochemical Tests
11.5.1.4. Others
11.5.2. Viruses
11.5.2.1. Molecular Tests
11.5.2.2. Culture
11.5.2.3. Others
11.5.3. Parasites
11.5.3.1. Ova and Parasite Microscopy
11.5.3.2. Molecular Tests
11.5.3.3. Others
11.6. North America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Test Type
11.7. North America Gastrointestinal Pathogen Testing Market Forecast, by Test Type
11.7.1. Molecular Tests
11.7.2. Culture
11.7.3. Biochemical Tests
11.7.4. Others
11.8. North America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Panel Type
11.9. North America Gastrointestinal Pathogen Testing Market Forecast, by Panel Type
11.9.1. Syndromic Full Multiplex Panels
11.9.2. Others
11.10. North America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by End-user
11.11. North America Gastrointestinal Pathogen Testing Market Forecast, by End-user
11.11.1. Hospitals
11.11.1.1. Public
11.11.1.2. Private
11.11.1.3. Others
11.11.2. Diagnostic Laboratories
11.11.3. Point-of-Care
11.11.4. Others
12. Europe Gastrointestinal Pathogen Testing Market Analysis
12.1. Key Insights: Europe Gastrointestinal Pathogen Testing Market
12.2. Europe Gastrointestinal Pathogen Testing Market Overview
12.3. Europe Gastrointestinal Pathogen Testing Market Forecast, by Country/Sub-region
12.3.1. Germany
12.3.2. U.K.
12.3.3. France
12.3.4. Italy
12.3.5. Spain
12.3.6. Rest of Europe
12.4. Europe Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Pathogen Type
12.5. Europe Gastrointestinal Pathogen Testing Market Forecast, by Pathogen Type
12.5.1. Bacteria
12.5.1.1. Molecular Tests
12.5.1.2. Culture
12.5.1.3. Biochemical Tests
12.5.1.4. Others
12.5.2. Viruses
12.5.2.1. Molecular Tests
12.5.2.2. Culture
12.5.2.3. Others
12.5.3. Parasites
12.5.3.1. Ova and Parasite Microscopy
12.5.3.2. Molecular Tests
12.5.3.3. Others
12.6. Europe Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Test Type
12.7. Europe Gastrointestinal Pathogen Testing Market Forecast, by Test Type
12.7.1. Molecular Tests
12.7.2. Culture
12.7.3. Biochemical Tests
12.7.4. Others
12.8. Europe Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Panel Type
12.9. Europe Gastrointestinal Pathogen Testing Market Forecast, by Panel Type
12.9.1. Syndromic Full Multiplex Panels
12.9.2. Others
12.10. Europe Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by End-user
12.11. Europe Gastrointestinal Pathogen Testing Market Forecast, by End-user
12.11.1. Hospitals
12.11.1.1. Public
12.11.1.2. Private
12.11.1.3. Others
12.11.2. Diagnostic Laboratories
12.11.3. Point-of-Care
12.11.4. Others
13. Asia Pacific Gastrointestinal Pathogen Testing Market Analysis
13.1. Key Insights: Asia Pacific Gastrointestinal Pathogen Testing Market
13.2. Asia Pacific Gastrointestinal Pathogen Testing Market Overview
13.3. Asia Pacific Gastrointestinal Pathogen Testing Market Forecast, by Country/Sub-region
13.3.1. China
13.3.2. Japan
13.3.3. India
13.3.4. Australia & New Zealand
13.3.5. Rest of Asia Pacific
13.4. Asia Pacific Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Pathogen Type
13.5. Asia Pacific Gastrointestinal Pathogen Testing Market Forecast, by Pathogen Type
13.5.1. Bacteria
13.5.1.1. Molecular Tests
13.5.1.2. Culture
13.5.1.3. Biochemical Tests
13.5.1.4. Others
13.5.2. Viruses
13.5.2.1. Molecular Tests
13.5.2.2. Culture
13.5.2.3. Others
13.5.3. Parasites
13.5.3.1. Ova and Parasite Microscopy
13.5.3.2. Molecular Tests
13.5.3.3. Others
13.6. Asia Pacific Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Test Type
13.7. Asia Pacific Gastrointestinal Pathogen Testing Market Forecast, by Test Type
13.7.1. Molecular Tests
13.7.2. Culture
13.7.3. Biochemical Tests
13.7.4. Others
13.8. Asia Pacific Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Panel Type
13.9. Asia Pacific Gastrointestinal Pathogen Testing Market Forecast, by Panel Type
13.9.1. Syndromic Full Multiplex Panels
13.9.2. Others
13.10. Asia Pacific Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by End-user
13.11. Asia Pacific Gastrointestinal Pathogen Testing Market Forecast, by End-user
13.11.1. Hospitals
13.11.1.1. Public
13.11.1.2. Private
13.11.1.3. Others
13.11.2. Diagnostic Laboratories
13.11.3. Point-of-Care
13.11.4. Others
14. Latin America Gastrointestinal Pathogen Testing Market Analysis
14.1. Key Insights: Latin America Gastrointestinal Pathogen Testing Market
14.2. Latin America Gastrointestinal Pathogen Testing Market Overview
14.3. Latin America Gastrointestinal Pathogen Testing Market Forecast, by Country/Sub-region
14.3.1. Brazil
14.3.2. Mexico
14.3.3. Rest of Latin America
14.4. Latin America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Pathogen Type
14.5. Latin America Gastrointestinal Pathogen Testing Market Forecast, by Pathogen Type
14.5.1. Bacteria
14.5.1.1. Molecular Tests
14.5.1.2. Culture
14.5.1.3. Biochemical Tests
14.5.1.4. Others
14.5.2. Viruses
14.5.2.1. Molecular Tests
14.5.2.2. Culture
14.5.2.3. Others
14.5.3. Parasites
14.5.3.1. Ova and Parasite Microscopy
14.5.3.2. Molecular Tests
14.5.3.3. Others
14.6. Latin America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Test Type
14.7. Latin America Gastrointestinal Pathogen Testing Market Forecast, by Test Type
14.7.1. Molecular Tests
14.7.2. Culture
14.7.3. Biochemical Tests
14.7.4. Others
14.8. Latin America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Panel Type
14.9. Latin America Gastrointestinal Pathogen Testing Market Forecast, by Panel Type
14.9.1. Syndromic Full Multiplex Panels
14.9.2. Others
14.10. Latin America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by End-user
14.11. Latin America Gastrointestinal Pathogen Testing Market Forecast, by End-user
14.11.1. Hospitals
14.11.1.1. Public
14.11.1.2. Private
14.11.1.3. Others
14.11.2. Diagnostic Laboratories
14.11.3. Point-of-Care
14.11.4. Others
15. Middle East & Africa Gastrointestinal Pathogen Testing Market Analysis
15.1. Key Insights: Middle East & Africa Gastrointestinal Pathogen Testing Market
15.2. Middle East & Africa Gastrointestinal Pathogen Testing Market Overview
15.3. Middle East & Africa Gastrointestinal Pathogen Testing Market Forecast, by Country/Sub-region
15.3.1. GCC Countries
15.3.2. South Africa
15.3.3. Rest of Middle East & Africa
15.4. Middle East & Africa Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Pathogen Type
15.5. Middle East & Africa Gastrointestinal Pathogen Testing Market Forecast, by Pathogen Type
15.5.1. Bacteria
15.5.1.1. Molecular Tests
15.5.1.2. Culture
15.5.1.3. Biochemical Tests
15.5.1.4. Others
15.5.2. Viruses
15.5.2.1. Molecular Tests
15.5.2.2. Culture
15.5.2.3. Others
15.5.3. Parasites
15.5.3.1. Ova and Parasite Microscopy
15.5.3.2. Molecular Tests
15.5.3.3. Others
15.6. Middle East & Africa Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Test Type
15.7. Middle East & Africa Gastrointestinal Pathogen Testing Market Forecast, by Test Type
15.7.1. Molecular Tests
15.7.2. Culture
15.7.3. Biochemical Tests
15.7.4. Others
15.8. Middle East & Africa Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Panel Type
15.9. Middle East & Africa Gastrointestinal Pathogen Testing Market Forecast, by Panel Type
15.9.1. Syndromic Full Multiplex Panels
15.9.2. Others
15.10. Middle East & Africa Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by End-user
15.11. Middle East & Africa Gastrointestinal Pathogen Testing Market Forecast, by End-user
15.11.1. Hospitals
15.11.1.1. Public
15.11.1.2. Private
15.11.1.3. Others
15.11.2. Diagnostic Laboratories
15.11.3. Point-of-Care
15.11.4. Others
16. Competition Landscape
16.1. Market Player – Competition Matrix (by tier and size of companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
16.3.1. bioMérieux SA
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Becton, Dickinson, and Company (BD)
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. QIAGEN
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Bio-Rad Laboratories, Inc.
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Thermo Fisher Scientific, Inc.
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Meridian Bioscience, Inc.
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Cepheid (Danaher Corporation)
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Laboratory Corporation of America Holdings
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Illumina, Inc.
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. DiaSorin S.p.A.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
16.3.11. Seegene, Inc.
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Product Portfolio
16.3.11.3. Financial Overview
16.3.11.4. SWOT Analysis
16.3.11.5. Strategic Overview
16.3.12. CerTest Biotec, S.L.
16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.12.2. Product Portfolio
16.3.12.3. Financial Overview
16.3.12.4. SWOT Analysis
16.3.12.5. Strategic Overview
16.3.13. Abbott
16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.13.2. Product Portfolio
16.3.13.3. Financial Overview
16.3.13.4. SWOT Analysis
16.3.13.5. Strategic Overview
16.3.14. F. Hoffmann-La Roche Ltd.
16.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.14.2. Product Portfolio
16.3.14.3. Financial Overview
16.3.14.4. SWOT Analysis
16.3.14.5. Strategic Overview
16.3.15. Genova Diagnostics
16.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.15.2. Product Portfolio
16.3.15.3. Financial Overview
16.3.15.4. SWOT Analysis
16.3.15.5. Strategic Overview
16.3.16. MicroGen DX
16.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.16.2. Product Portfolio
16.3.16.3. Financial Overview
16.3.16.4. SWOT Analysis
16.3.16.5. Strategic Overview
16.3.17. Quidel Corporation
16.3.17.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.17.2. Product Portfolio
16.3.17.3. Financial Overview
16.3.17.4. SWOT Analysis
16.3.17.5. Strategic Overview